CARDIOVERSE INFOGRAPHIC (IMAGE)
Caption
Over 90% of drugs fail clinical trials, often because hidden cardiac risks appear late in the approval process after years of work and enormous costs. The Jackson Laboratory is leading development of CARDIOVERSE, an Al platform to predict these risks by integrating data from genetically diverse mice and human stem cells.
Credit
The Jackson Laboratory
Usage Restrictions
Use with proper credit
License
Original content